{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T03:12:46Z","timestamp":1792293166642,"version":"4.4.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.pnpbp.2022.110641","type":"journal-article","created":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T08:57:53Z","timestamp":1663405073000},"page":"110641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort"],"prefix":"10.1016","volume":"120","author":[{"given":"O.","family":"Godin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Szoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Boyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Aouizerate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Schorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Capdevielle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Chereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Coulon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Dassing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Dubertret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Etain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Leignier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.M.","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Mallet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Misdrahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Passerieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sch\u00fcrhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Leboyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Fond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2022.110641_bb0005","first-page":"674","article-title":"D\u00e9velopper la psychonutrition dans la pratique clinique psychiatrique","volume":"180","author":"Achour","year":"2022","journal-title":"Ann. M\u00e9d.-Psychol. Rev. Psychiat."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome--a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0015","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0020","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.psyneuen.2016.08.020","article-title":"Longitudinal association of antidepressant medication use with metabolic syndrome: results of a 9-year follow-up of the D.E.S.I.R. cohort study","volume":"74","author":"Azevedo Da Silva","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0025","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4103\/2230-8210.91197","article-title":"Tobacco and metabolic syndrome","volume":"16","author":"Balhara","year":"2012","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0030","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1176\/appi.ps.003622012","article-title":"Clinically significant improved fitness and weight loss among overweight persons with serious mental illness","volume":"64","author":"Bartels","year":"2013","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0035","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1176\/appi.ajp.2014.14030357","article-title":"Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes","volume":"172","author":"Bartels","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0040","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5498\/wjp.v11.i7.316","article-title":"Selective serotonin reuptake inhibitors and risk reduction for cardiovascular disease in patients with schizophrenia: a controversial but promising approach","volume":"11","author":"Bellon","year":"2021","journal-title":"World J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0045","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0447.1998.tb09960.x","article-title":"Calgary depression scale for schizophrenia: a study of the validity of a French-language version in a population of schizophrenic patients","volume":"97","author":"Bernard","year":"1998","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0050","doi-asserted-by":"crossref","first-page":"148","DOI":"10.4306\/pi.2013.10.2.148","article-title":"Relationship between SSRIs and metabolic syndrome abnormalities in patients with generalized anxiety disorder: a prospective study","volume":"10","author":"Beyazy\u00fcz","year":"2013","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0055","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41574-020-00427-4","article-title":"Circadian rhythms and the gut microbiota: from the metabolic syndrome to cancer","volume":"16","author":"Bishehsari","year":"2020","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0060","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.schres.2010.02.1030","article-title":"Healthy lifestyle habits and 10-year cardiovascular risk in schizophrenia spectrum disorders: an analysis of the impact of smoking tobacco in the CLAMORS schizophrenia cohort","volume":"119","author":"Bobes","year":"2010","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0065","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1017\/S0033291716003366","article-title":"The relationship between cognitive impairment in schizophrenia and metabolic syndrome: a systematic review and meta-analysis","volume":"47","author":"Bora","year":"2017","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0070","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1753-4887.2011.00446.x","article-title":"Relationship between smoking and metabolic syndrome","volume":"69","author":"Cena","year":"2011","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0075","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1177\/0269881116645254","article-title":"BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment","volume":"30","author":"Cooper","year":"2016","journal-title":"J. Psychopharmacol. (Oxford)"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1001\/jamapsychiatry.2017.0624","article-title":"Efficacy of 42 pharmacologic Cotreatment strategies added to antipsychotic monotherapy in schizophrenia: systematic overview and quality appraisal of the Meta-analytic evidence","volume":"74","author":"Correll","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0085","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/wps.20420","article-title":"Prevalence, incidence and mortality from cardiovascular disease in patients with pooled and specific severe mental illness: a large-scale meta-analysis of 3,211,768 patients and 113,383,368 controls","volume":"16","author":"Correll","year":"2017","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0090","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1186\/s12889-016-3170-2","article-title":"Association between depressive symptoms, use of antidepressant medication and the metabolic syndrome: the Maine-Syracuse study","volume":"16","author":"Crichton","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0095","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1123\/jpah.8.6.858","article-title":"Reproducibility and validity of the French version of the long international physical activity questionnaire in patients with type 2 diabetes","volume":"8","author":"Crini\u00e8re","year":"2011","journal-title":"J. Phys. Act. Health"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0100","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJMoa1214530","article-title":"A behavioral weight-loss intervention in persons with serious mental illness","volume":"368","author":"Daumit","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2337\/diacare.29.01.06.dc05-1320","article-title":"Metabolic syndrome: risk factor distribution and 18-year mortality in the multiple risk factor intervention trial","volume":"29","author":"Eberly","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0110","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0115","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S2215-0366(17)30429-7","article-title":"Cause-specific life-years lost in people with mental disorders: a nationwide, register-based cohort study","volume":"4","author":"Erlangsen","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0120","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/schbul\/sbaa153","article-title":"Comorbid major depressive disorder in schizophrenia: a systematic review and Meta-analysis","volume":"47","author":"Etchecopar-Etchart","year":"2021","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0125","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.irn.2015.08.001","article-title":"Effective cessation strategies for smokers with schizophrenia","volume":"124","author":"Evins","year":"2015","journal-title":"Int. Rev. Neurobiol."},{"issue":"Suppl. 11","key":"10.1016\/j.pnpbp.2022.110641_bb0130","first-page":"37","article-title":"Weight gain and antidepressants","volume":"61","author":"Fava","year":"2000","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0135","series-title":"Structured Clinical Interview for the DSM-IV Axis I Disorders","author":"First","year":"1996"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0140","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2016.10.023","article-title":"Validation study of the medication adherence rating scale. Results from the FACE-SZ national dataset","volume":"182","author":"Fond","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109927","article-title":"Confirmations, advances and recommendations for the daily care of schizophrenia based on the French national FACE-SZ cohort","volume":"101","author":"Fond","year":"2020","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"21","key":"10.1016\/j.pnpbp.2022.110641_bb0150","article-title":"Barriers in psychiatrists\u2019 mind to active smoking cessation promotion in severe psychiatric disorders","volume":"S0013-7006","author":"Fond","year":"2021","journal-title":"Encephale"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and Meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0160","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.encep.2021.01.007","article-title":"Which antipsychotics should be chosen for the treatment of schizo-obsessive disorder?","volume":"48","author":"Garosi","year":"2022","journal-title":"Encephale"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0165","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.schres.2015.07.047","article-title":"Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: results from the FACE-SZ cohort","volume":"168","author":"Godin","year":"2015","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0170","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17m12007","article-title":"Metabolic syndrome and illness severity predict relapse at 1-year follow-up in schizophrenia: the FACE-SZ cohort","volume":"79","author":"Godin","year":"2018","journal-title":"J. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.pnpbp.2022.110641_bb0175","first-page":"35","article-title":"The PANSS (positive and negative symptom) scale","volume":"23 Spec","author":"Guelfi","year":"1997","journal-title":"Encephale"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1176\/appi.ajp.2016.15081035","article-title":"Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and Meta-analysis","volume":"173","author":"Helfer","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0185","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1001\/jama.2020.4501","article-title":"Trends in the prevalence of metabolic syndrome in the United States, 2011-2016","volume":"323","author":"Hirode","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0190","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/archinte.164.10.1066","article-title":"Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women","volume":"164","author":"Hu","year":"2004","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41398-020-0785-y","article-title":"Adjunctive metformin for antipsychotic-induced dyslipidemia: a meta-analysis of randomized, double-blind, placebo-controlled trials","volume":"10","author":"Jiang","year":"2020","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0200","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1089\/met.2014.0124","article-title":"Association between cotinine-verified smoking status and metabolic syndrome: analyses of Korean National Health and nutrition examination surveys 2008-2010","volume":"13","author":"Kang","year":"2015","journal-title":"Metab. Syndr. Relat. Disord."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0205","article-title":"Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort","author":"Korchia","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0210","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/1471-244X-11-173","article-title":"Prevalence of metabolic syndrome in patients with schizophrenia, and metabolic changes after 3 months of treatment with antipsychotics--results from a German observational study","volume":"11","author":"Kraemer","year":"2011","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0215","series-title":"Encyclopedia of Behavioral Medicine","first-page":"1919","article-title":"Structured clinical interview for DSM-IV (SCID)","author":"K\u00fcbler","year":"2013"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0220","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/schbul\/sbu001","article-title":"Dose equivalents for second-generation antipsychotics: the minimum effective dose method","volume":"40","author":"Leucht","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyab038","article-title":"Smoking affects the patterns of metabolic disorders and metabolic syndrome in patients with first-episode drug-naive schizophrenia - a large sample study based on Chinese Han population","author":"Li","year":"2021","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0230","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.jad.2013.03.010","article-title":"A prospective, longitudinal study of metabolic syndrome in patients with bipolar disorder and schizophrenia","volume":"150","author":"Malhotra","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0235","series-title":"WHO Guidelines Approved by the Guidelines Review Committee","author":"Management of Physical Health Conditions in Adults with Severe Mental Disorders","year":"2018"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0240","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s41591-021-01399-2","article-title":"Fecal microbial transplantation and fiber supplementation in patients with severe obesity and metabolic syndrome: a randomized double-blind, placebo-controlled phase 2 trial","volume":"27","author":"Mocanu","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0245","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0250","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.jacc.2006.05.009","article-title":"The reduction of inflammatory biomarkers by statin, fibrate, and combination therapy among diabetic patients with mixed dyslipidemia: the DIACOR (diabetes and combined lipid therapy regimen) study","volume":"48","author":"Muhlestein","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0260","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/M19-0563","article-title":"Altered risk for cardiovascular events with changes in the metabolic syndrome status: a Nationwide population-based study of approximately 10 million persons","volume":"171","author":"Park","year":"2019","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0265","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neubiorev.2016.07.003","article-title":"Depression and cardiovascular disease: epidemiological evidence on their linking mechanisms","volume":"74","author":"Penninx","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0270","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1176\/ps.2009.60.2.147","article-title":"Premature mortality from general medical illnesses among persons with bipolar disorder: a review","volume":"60","author":"Roshanaei-Moghaddam","year":"2009","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0275","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/eip.12428","article-title":"Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care","volume":"12","author":"Saloojee","year":"2018","journal-title":"Early Interv. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0280","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.eurpsy.2015.05.004","article-title":"A national network of schizophrenia expert centres: an innovative tool to bridge the research-practice gap","volume":"30","author":"Sch\u00fcrhoff","year":"2015","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0285","article-title":"The 10-year findings from the FondaMental academic Center of Expertise for schizophrenia (FACE-SZ): review and recommendations for clinical practice","author":"Sch\u00fcrhoff","year":"2018","journal-title":"Encephale"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0290","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.dsx.2018.08.014","article-title":"Prevalence of metabolic syndrome in Iranian patients with schizophrenia: a systematic review and meta-analysis","volume":"13","author":"Shojaeimotlagh","year":"2019","journal-title":"Diabetes Metab. Syndr."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0295","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12888-016-1049-5","article-title":"Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis","volume":"16","author":"de Silva","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156208","article-title":"Metformin for clozapine associated obesity: a systematic review and Meta-analysis","volume":"11","author":"Siskind","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0305","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2021.625935","article-title":"Clinical, biochemical and genetic variables associated with metabolic syndrome in patients with schizophrenia Spectrum disorders using second-generation antipsychotics: a systematic review","volume":"12","author":"Sneller","year":"2021","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0310","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.jacc.2015.06.1328","article-title":"The CardioMetabolic health Alliance: working toward a new care model for the metabolic syndrome","volume":"66","author":"Sperling","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0315","doi-asserted-by":"crossref","first-page":"E6700","DOI":"10.3390\/ijerph17186700","article-title":"Risk factors of metabolic syndrome in community-dwelling people with schizophrenia","volume":"17","author":"Sun","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0320","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.bbi.2020.04.034","article-title":"Omega-3 fatty acids ameliorate cognitive dysfunction in schizophrenia patients with metabolic syndrome","volume":"88","author":"Tang","year":"2020","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0325","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.addbeh.2017.07.005","article-title":"Predictors of smoking cessation group treatment engagement among veterans with serious mental illness","volume":"75","author":"Travaglini","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0330","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.genhosppsych.2014.10.011","article-title":"Weight gain and associated factors in patients using newer antidepressant drugs","volume":"37","author":"Uguz","year":"2015","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0335","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/wps.20252","article-title":"Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis","volume":"14","author":"Vancampfort","year":"2015","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0340","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/wps.20614","article-title":"The impact of pharmacological and non-pharmacological interventions to improve physical health outcomes in people with schizophrenia: a meta-review of meta-analyses of randomized controlled trials","volume":"18","author":"Vancampfort","year":"2019","journal-title":"World Psychiatry"},{"key":"10.1016\/j.pnpbp.2022.110641_bb0345","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1479-5868-7-39","article-title":"A systematic review of the evidence for Canada\u2019s physical activity guidelines for adults","volume":"7","author":"Warburton","year":"2010","journal-title":"Int. J. Behav. Nutr. Phys. Act."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0350","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3390\/jpm11100987","article-title":"Lipid and energy metabolism of the gut microbiota is associated with the response to probiotic Bifidobacterium breve strain for anxiety and depressive symptoms in schizophrenia","volume":"11","author":"Yamamura","year":"2021","journal-title":"J. Personal. Med."},{"key":"10.1016\/j.pnpbp.2022.110641_bb0355","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.euroneuro.2016.07.010","article-title":"A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome","volume":"26","author":"Zimbron","year":"2016","journal-title":"Eur. Neuropsychopharmacol."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584622001336?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584622001336?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:04:42Z","timestamp":1759521882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584622001336"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":70,"alternative-id":["S0278584622001336"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110641","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3-year incidence and predictors of metabolic syndrome in schizophrenia in the national FACE-SZ cohort","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2022.110641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110641"}}